Related Experiment Videos
Directed evolution of PDZ variants to generate high-affinity detection reagents
Marc Ferrer1, Jim Maiolo, Patricia Kratz
1Department of Automated Biotechnology, Merck and Co., Inc., 502-503 Louise Lane, North Wales, PA 19454, USA.
Protein Engineering, Design & Selection : PEDS
|April 12, 2005
Summary
Researchers developed new PDZ domains using directed evolution for protease assays. This method enhances drug discovery by creating sensitive, reliable, and cost-effective detection reagents for protease activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- High-throughput protease assays are crucial for identifying protease inhibitors as potential therapeutics.
- Antibodies and natural PDZ domains have limitations in detecting proteolysis products due to production challenges and limited specificity.
- Existing methods for detecting protease activity in high-throughput assays are often unreliable, slow, and costly.
Purpose of the Study:
- To demonstrate directed evolution as an efficient method for creating novel PDZ domains for protease activity detection.
- To engineer PDZ domains with enhanced affinity and specificity for protease cleavage products.
- To develop more reliable, sensitive, and cost-effective reagents for drug discovery.
Main Methods:
- Utilized phage display technology for the directed evolution of PDZ domains.
- Selected and characterized PDZ domain variants with improved affinity for a specific peptide cleavage product.
- Analyzed amino acid substitutions responsible for altered specificity and binding affinity.
Main Results:
- Successfully engineered three NHERF PDZ domain variants with up to 25-fold increased affinity for an HIV protease cleavage product.
- Achieved high affinities as low as 620 nM for the engineered PDZ domains.
- Demonstrated a greater than 5-fold improvement in assay sensitivity using the engineered reagents.
- Identified specific amino acid substitutions contributing to enhanced binding and phage display efficiency.
Conclusions:
- Directed evolution via phage display is an effective strategy for creating novel PDZ domains with tailored specificities.
- Engineered PDZ domains offer significant improvements in sensitivity and reliability for high-throughput protease assays.
- This approach provides a pathway for developing more accessible and cost-effective reagents for protease inhibitor drug discovery.